METTL3 and Alzheimer disease: Furthermore, the expression level of METTL3 in aortic tissues of TAAD patients was significantly higher than that in non-AD subjects, and METTL3 promoted the degradation of the mRNAs of SLC7A11 and FSP1 to inhibit their protein expression in primary cultured human aorta SMCs (HASMCs).